{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Heinen A"],"funding":["German Research Foundation","Dr. Sigrid-Worch-Pöhler-Stiftung"],"pagination":["46-58"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6319026"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["27(1)"],"pubmed_abstract":["Insulin-like growth factor 1 (IGF1) is an anabolic hormone that controls the growth and metabolism of many cell types. However, IGF1 also mediates cardio-protective effects after acute myocardial infarction (AMI), but the underlying mechanisms and cellular targets are not fully understood. Here we demonstrate that short-term IGF1 treatment for 3 days after AMI improved cardiac function after 1 and 4 weeks. Regional wall motion was improved in ischemic segments, scar size was reduced, and capillary density increased in the infarcted area and the border zone. Unexpectedly, inducible inactivation of the IGF1 receptor (IGF1R) in cardiomyocytes did not attenuate the protective effect of IGF1. Sequential cardiac transcriptomic analysis indicated an altered myeloid cell response in the acute phas"],"journal":["Molecular therapy : the journal of the American Society of Gene Therapy"],"pubmed_title":["IGF1 Treatment Improves Cardiac Remodeling after Infarction by Targeting Myeloid Cells."],"pmcid":["PMC6319026"],"funding_grant_id":["TP A06"],"pubmed_authors":["Boy J","Nederlof R","Lang P","Tschaidse T","Raupach A","Alter C","Reffelt H","Godecke S","Vasilevska J","Spychala A","Panjwani P","Petzsch P","Grandoch M","Petz A","Heinen A","Fischer JW","Godecke A","Kohrer K"],"additional_accession":[]},"is_claimable":false,"name":"IGF1 Treatment Improves Cardiac Remodeling after Infarction by Targeting Myeloid Cells.","description":"Insulin-like growth factor 1 (IGF1) is an anabolic hormone that controls the growth and metabolism of many cell types. However, IGF1 also mediates cardio-protective effects after acute myocardial infarction (AMI), but the underlying mechanisms and cellular targets are not fully understood. Here we demonstrate that short-term IGF1 treatment for 3 days after AMI improved cardiac function after 1 and 4 weeks. Regional wall motion was improved in ischemic segments, scar size was reduced, and capillary density increased in the infarcted area and the border zone. Unexpectedly, inducible inactivation of the IGF1 receptor (IGF1R) in cardiomyocytes did not attenuate the protective effect of IGF1. Sequential cardiac transcriptomic analysis indicated an altered myeloid cell response in the acute phas","dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Jan","modification":"2026-05-01T20:26:43.442Z","creation":"2021-02-20T23:06:42Z"},"accession":"S-EPMC6319026","cross_references":{"pubmed":["30528085"],"doi":["10.1016/j.ymthe.2018.10.020"]}}